21 November 2017
News and Views
Links and Services
A study in the latest issue of the Journal of Clinical Gastroenterology evaluates the use of simvastatin in the treatment of nonalcoholic steatohepatitis.
Nonalcoholic fatty liver disease (NASH), as the hepatic manifestation of the metabolic syndrome,
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors